Pharmaceuticals Global On demand · 24-48h

Global Drug or Substance Abuse Testing Market Strategic Research Report

Global Drug or Substance Abuse Testing Market Strategic Rese…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Drug or Substance Abuse Testing Market
$2.47B2025
8.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Urine Testing, Saliva Testing, Blood Testing, Hair and Sweat Testing, Others

By Application: Hospital, Law Enforcement, Drug Treatment Center, Laboratory, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Abbott, Thermo Fisher, Roche, Siemens Healthineers, Wondfo Biotech, Randox, OraSure, Draeger, InTec, Orient Gene, Hangzhou Biotest, Assure Tech, Aotai Bio

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 115 pages
Market size 2025
$2.47B
Billion USD
Forecast CAGR
8.4%
2025-2032
Forecast 2032
$4.3B
Projected
Области
5
Asia Pacific · Latin America · MEA · Europe · North America

Обзор

Scope of the Report

The global Drug or Substance Abuse Testing market size is predicted to grow from US$ 2,470 million in 2025 to US$ 4,291 million in 2032; it is expected to grow at a CAGR of 8.4% from 2026 to 2032.

Drugs of Abuse Testing Devices are used to test detect the presence of drugs such as marijuana, cocaine, opiates, methamphetamine, amphetamines, PCP, benzodiazepine, barbiturates, methadone, tricyclic antidepressants, ecstasy, and oxycodone etc in the urine, blood, saliva, hair, or sweat.

The global drug market is expanding year by year, and the problem of drug abuse is spreading. With the expansion of the world drug market and the continuous emergence of various new drugs, the cost of drug abuse is reduced and the number of drug users is increasing year by year. The demand for drug abuse detection kit market will only be increasing. The market development potential is still very huge. Owing to rise in cocaine production, Asia Pacific is also emerging as the hubs for cocaine trafficking and consumption. Owing to the increase of cocaine seizures, a paradigm shift toward an increase in users seeking treatment against drugs abuse has also been witnessed, which again has raised the importance of drug abuse testing kits globally.

In order to prevent deaths caused by overdose of drugs the governments of a number of countries have funded programs against drug abuse. The global governments spent large million in 2021 for screening, brief intervention and referral to treatment for drug usage. Also a number of countries have made it legal for workplaces to test their employees for drugs. The rise of supervision will undoubtedly drive the growth of the market.

The prevalence of various acute and chronic diseases has been rising in recent years. The large demand for rapid diagnosis and appropriate treatment has promoted the significant growth of POCT market. Drug abuse detection kit is a branch of POCT industry. The rapid and stable development of POCT industry has driven the development of drug abuse detection.

This report presents a comprehensive overview of the global Drug or Substance Abuse Testing market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Urine Testing
  • Saliva Testing
  • Blood Testing
  • Hair and Sweat Testing
  • Others

Segment by Application

  • Hospital
  • Law Enforcement
  • Drug Treatment Center
  • Laboratory
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Drug or Substance Abuse Testing market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Law Enforcement, Drug Treatment Center evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Drug or Substance Abuse Testing Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.47B
2025
Forecast
$4.3B
2032
CAGR
8.4%
2025–2032
Области
5
global
Key companies
AbbottThermo FisherRocheSiemens HealthineersWondfo BiotechRandoxOraSureDraeger
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Urine TestingSaliva TestingBlood TestingHair and Sweat TestingOthers
By Application
HospitalLaw EnforcementDrug Treatment CenterLaboratoryOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Urine Testing
  • 3.1.3 Saliva Testing
  • 3.1.4 Blood Testing
  • 3.1.5 Hair and Sweat Testing
  • 3.1.6 Others
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Law Enforcement
  • 4.1.4 Drug Treatment Center
  • 4.1.5 Laboratory
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Abbott
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Thermo Fisher
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Roche
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Siemens Healthineers
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Wondfo Biotech
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Randox
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 OraSure
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Draeger
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 InTec
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Orient Gene
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Hangzhou Biotest
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Assure Tech
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Aotai Bio
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Drug or Substance Abuse Testing market size?
The global Drug or Substance Abuse Testing market is estimated at US$ 2.47 billion in 2025 (base year) and is projected to reach US$ 4.29 billion by 2032.
What growth rate is expected for the Drug or Substance Abuse Testing market through 2032?
The market is expected to grow at a CAGR of 8.4% from 2026 to 2032, expanding from US$ 2.47 billion in 2025 to US$ 4.29 billion in 2032, roughly 1.7 times its base-year value.
How is Drug or Substance Abuse Testing defined?
Drugs of Abuse Testing Devices are used to test detect the presence of drugs such as marijuana, cocaine, opiates, methamphetamine, amphetamines, PCP, benzodiazepine, barbiturates, methadone, tricyclic antidepressants, ecstasy, and oxycodone etc in the urine, blood, saliva, hair, or sweat.
What are the main segments of the Drug or Substance Abuse Testing market by type?
By type, the market is segmented into Urine Testing, Saliva Testing, Blood Testing, Hair and Sweat Testing and Others.
Which applications drive demand in the Drug or Substance Abuse Testing market?
Key applications covered include Hospital, Law Enforcement, Drug Treatment Center, Laboratory and Others.
Who are the key players in the Drug or Substance Abuse Testing market?
Key players profiled include Abbott, Thermo Fisher, Roche, Siemens Healthineers, Wondfo Biotech, Randox, OraSure and Draeger, among 13 companies covered in total.
Which regions and countries are covered for Drug or Substance Abuse Testing?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Drug or Substance Abuse Testing market?
The rapid and stable development of POCT industry has driven the development of drug abuse detection.
Who should buy the Drug or Substance Abuse Testing market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Law Enforcement and Drug Treatment Center, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Drug or Substance Abuse Testing market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.